# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Tech stocks kicked off the week on the negative note, driven lower by concerns over weaker-than-expected demand for Apple Inc. ...
Melius Research analyst Ben Reitzes upgrades Oracle (NYSE:ORCL) from Hold to Buy.
Jefferies analyst Brent Thill maintains Oracle (NYSE:ORCL) with a Buy and raises the price target from $170 to $190.
Tech stocks could continue to head northward despite stretched valuations, according to a bullish analyst.
The entire 25-member staff of Annapurna Interactive, including top executives, resigned en masse following failed talks about t...
These ten stocks saw significant gains last week, with Summit Therapeutics up 98.32% and BioNTech up 31.77%. Analysts also rais...